Novartis India Ltd

₹ 674 -0.96%
03 Oct - close price
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Therapeutic Segments
The company's pharmaceutical business is focused on bone & pain, calcium portfolio, gynaecology and neurosciences. Its generics business is focused on gynaecology, anti-TB and anti-infectives.[1]

  • Market Cap 1,665 Cr.
  • Current Price 674
  • High / Low 927 / 565
  • Stock P/E 18.5
  • Book Value 280
  • Dividend Yield 1.48 %
  • ROCE 6.09 %
  • ROE 5.84 %
  • Face Value 5.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of -9.43% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 3.33% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
109 118 117 94 92 96 94 99 98 104 99 98 121
115 121 108 83 88 86 97 84 90 97 92 93 89
Operating Profit -5 -3 9 11 4 10 -3 15 8 7 7 6 32
OPM % -5% -2% 8% 12% 5% 11% -3% 15% 8% 7% 7% 6% 26%
11 10 7 8 7 6 8 12 6 6 6 -35 27
Interest 1 2 2 2 2 2 2 3 2 2 1 0 0
Depreciation 3 3 3 4 3 3 3 3 3 3 3 1 1
Profit before tax 1 2 11 14 6 11 1 22 10 9 8 -31 57
Tax % 40% 318% 32% 50% 32% 32% 204% 56% 36% 24% 24% 25% 7%
Net Profit 1 -5 8 7 4 8 -1 10 6 7 6 -23 52
EPS in Rs 0.32 -2.11 3.13 2.75 1.78 3.05 -0.29 3.93 2.54 2.84 2.57 -9.47 21.21
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
749 842 901 859 870 690 656 564 491 438 381 400 423
595 698 810 861 874 656 631 570 478 426 355 373 372
Operating Profit 154 144 90 -1 -4 34 25 -6 12 12 27 27 51
OPM % 21% 17% 10% -0% -0% 5% 4% -1% 2% 3% 7% 7% 12%
67 84 83 95 101 207 71 172 78 36 33 -17 4
Interest 0 1 0 0 0 0 1 6 2 6 8 5 4
Depreciation 2 3 4 4 4 3 4 3 3 13 12 10 8
Profit before tax 219 225 169 90 93 237 92 158 86 29 40 -4 43
Tax % 33% 32% 29% -10% 15% 16% 38% 50% 40% 65% 48% 3%
Net Profit 147 152 120 99 79 198 57 78 52 10 21 -4 42
EPS in Rs 45.89 47.56 37.46 30.83 24.75 62.04 20.33 31.74 20.97 4.08 8.46 -1.51 17.15
Dividend Payout % 22% 21% 27% 32% 40% 16% 49% 32% 48% 245% 118% -663%
Compounded Sales Growth
10 Years: -7%
5 Years: -9%
3 Years: -7%
TTM: 9%
Compounded Profit Growth
10 Years: -12%
5 Years: -6%
3 Years: -8%
TTM: 295%
Stock Price CAGR
10 Years: 0%
5 Years: 1%
3 Years: 3%
1 Year: -17%
Return on Equity
10 Years: 9%
5 Years: 5%
3 Years: 3%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
16 16 16 16 16 16 14 12 12 12 12 12
Reserves 687 802 884 945 986 1,178 906 721 747 708 699 679
0 0 0 0 0 0 0 0 0 68 62 24
190 216 241 241 244 239 230 377 223 289 229 242
Total Liabilities 893 1,034 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958
8 10 10 8 8 6 6 5 15 76 64 24
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
885 1,023 1,131 1,194 1,238 1,426 1,144 1,106 967 1,001 938 934
Total Assets 893 1,034 1,141 1,202 1,246 1,433 1,150 1,111 982 1,078 1,002 958

Cash Flows

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
91 75 7 -5 -60 57 -41 161 -194 -23 -69 39
-22 -43 -16 22 719 -630 424 69 274 56 95 87
-38 -37 -37 -38 -38 -39 -332 -268 -30 -41 -37 -36
Net Cash Flow 31 -5 -46 -20 622 -612 51 -38 50 -9 -11 90

Ratios

Figures in Rs. Crores

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 31 30 33 33 35 27 23 28 34 31 37 41
Inventory Days 72 93 108 96 103 92 104 84 111 117 119 117
Days Payable 106 115 117 100 98 89 87 158 168 145 137 148
Cash Conversion Cycle -4 8 24 29 40 30 40 -45 -23 3 19 10
Working Capital Days 263 285 317 353 6 -35 -14 -99 7 9 75 -19
ROCE % 34% 30% 20% 10% 9% 22% 9% 17% 12% 5% 6% 6%

Shareholding Pattern

Numbers in percentages

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68
0.09 0.14 0.04 0.04 0.05 0.05 0.06 0.06 0.03 0.09 0.12 0.14
0.94 0.90 0.82 0.82 0.82 0.79 0.78 0.84 0.78 0.78 0.77 0.78
28.29 28.28 28.46 28.46 28.45 28.48 28.48 28.43 28.51 28.46 28.43 28.41

Documents